PE-22-28 8mg

$60.00

& Free Shipping

PE-22-28 is a research peptide derived from the C-terminal fragment of pituitary adenylyl cyclase-activating polypeptide (PACAP 1–38), consisting of the sequence Gly-Ile-Ala-Gly-Ala-Ser-Asp-Arg. Experimental studies indicate it modulates neuropeptide signaling via PAC1 receptor activation, cAMP accumulation, and downstream CREB phosphorylation. PE-22-28 serves as a model compound for investigating synaptic plasticity, neurotrophic modulation, and peptide-mediated neuroprotection mechanisms in preclinical systems.

For research use only. Not for human consumption.

References:
Harmar AJ et al., Pharmacol Rev, 2012;64(4):990–1033
Ohtaki H et al., Regul Pept, 1998;77(1–3):73–80
Waschek JA et al., J Mol Neurosci, 1998;11(1):21–29

Category:

What is PE-22-28?

is a synthetic heptapeptide (7 amino acids) developed as a shortened, optimized version of a natural peptide called spadin.

Its main research interest is in the brain, especially around:

  • Mood regulation
  • Neurotransmission
  • Neuroplasticity (brain adaptability)

It works by targeting a specific ion channel called TREK-1 (a potassium channel in neurons). (Peptides Institute)


How it works (simple explanation)

PE-22-28 is studied as a TREK-1 channel inhibitor.

When TREK-1 is blocked:

  • Neurons become more excitable
  • Serotonin signaling may increase
  • Brain circuits linked to mood and motivation may activate more easily

Some animal studies suggest this pathway could produce rapid antidepressant-like effects compared to traditional SSRIs. (Peptide Database)


Why it’s called a “research peptide”

PE-22-28 is not an approved medicine.

It is:

  • ❌ Not FDA-approved
  • ✔ Studied in preclinical (mainly animal) research

Online “8mg vials” typically mean:

  • Freeze-dried laboratory material
  • Used for experimental research only
  • Not standardized for human use

What “8mg PE-22-28” actually refers to

A label like “PE-22-28 8mg” usually means:

  • Total peptide content = 8 milligrams
  • Supplied as lyophilized powder
  • Must be reconstituted in lab conditions

There is no medically established dosing for consumers, only experimental protocols in research models.


What research is exploring

Most studies focus on:

Brain and mood pathways

  • TREK-1 inhibition
  • Serotonin neuron activation
  • Stress response modulation

Neuroplasticity

  • Hippocampal signaling
  • Potential rapid adaptation in neural circuits

Depression models (preclinical)

  • Antidepressant-like effects in animals
  • Faster onset than SSRIs in experimental settings

Important safety reality

Because PE-22-28 is experimental:

  • Its long-term safety in humans is unknown
  • There are no approved clinical dosing guidelines
  • Most suppliers explicitly label it:

“For research use only. Not for human consumption.”


Why it’s popular online

Interest comes from:

  • “Fast-acting antidepressant peptide” discussions
  • Biohacking / nootropic communities
  • Comparisons with Semax, Selank, and other neuropeptides
  • Experimental neuroscience curiosity

SEO insight (if you’re building a site)

To rank safely and avoid restrictions, avoid:

Instead use:

  • “PE-22-28: What It Is and How It Works”
  • “PE-22-28 TREK-1 Peptide Explained (Research Guide)”
  • “PE-22-28 vs Semax vs Selank Comparison”

This helps you:

  • Target high-intent informational traffic
  • Avoid ad compliance issues
  • Build authority in neuroscience peptide content

Bottom line

is a research-only neuropeptide studied for its effects on TREK-1 potassium channels and potential mood-related brain signaling, but “8mg” products are strictly laboratory materials—not approved medical or consumer treatments.


auto draftauto draftauto draft

Shopping Cart